title: Changes in glucose-elicited blood metabolite responses following weight loss and long term weight maintenance in obese individuals with impaired glucose tolerance.
abstract: OBJECTIVE
  Weight loss improves insulin sensitivity and glucose tolerance in obese subjects with impaired glucose tolerance (IGT), but the long term dynamic effects on blood metabolites other than glucose during an oral glucose tolerance test (OGTT), are largely unknown. Here, we studied changes in OGTT-elicited metabolite patterns in obese subjects during a diet-induced weight loss study.
  
  
  METHODS
  Blood samples from 14 obese individuals with IGT were collected at 0, 30 and 120 min during a standard 75 g OGTT at baseline (BMI 44 ± 2 kg/m(2)), after weight loss (BMI 36 ± 2 kg/m(2)) and after weight maintenance (BMI 35 ± 2 kg/m(2)). Serum metabolite levels were analyzed by gas chromatography/mass spectrometry and compared to a lean glucose tolerant group.
  
  
  RESULTS
  Changes in the OGTT-elicited metabolite patterns occurred differentially during weight loss and weight maintenance. Enhanced suppression of aromatic amino acids were associated with decreased insulinogenic index observed after weight loss (tyrosine: r=0.72, p=0.013; phenylalanine: r=0.63, p=0.039). The OGTT-elicited suppression and/or lack of increase in levels of glutamate, glutamine, isoleucine, leucine, and the fatty acids laurate, oleate and palmitate, improved towards the lean profile after weight maintenance, paralleling an improvement in glucose tolerance. The greater heterogeneity in the response before and after weight loss in the obese, compared to lean subjects, was markedly reduced after weight maintenance.
  
  
  CONCLUSIONS
  Diet-induced weight loss followed by weight maintenance results in changes in metabolite profiles associated with either hepatic insulin sensitivity or peripheral glucose tolerance. Our results highlight the importance of evaluating the effects of weight loss and weight maintenance separately.
authors.affiliation: Department of Clinical Sciences Malmö, Clinical Obesity, Lund University Diabetes Center, Lund University, Sweden. Electronic address: nina.geidenstam@med.lu.se.
authors.forename: Nina
authors.initials: N
authors.lastname: Geidenstam
authors.affiliation: Department of Clinical Sciences Malmö, Clinical Obesity, Lund University Diabetes Center, Lund University, Sweden.
authors.forename: Anders P H
authors.initials: AP
authors.lastname: Danielsson
authors.affiliation: Department of Clinical Sciences Malmö, Unit of Molecular Metabolism, Lund University Diabetes Center, Lund University, Sweden.
authors.forename: Peter
authors.initials: P
authors.lastname: Spégel
authors.affiliation: Department of Clinical Sciences Malmö, Clinical Obesity, Lund University Diabetes Center, Lund University, Sweden; Steno Diabetes Center A/S, Gentofte, Denmark.
authors.forename: Martin
authors.initials: M
authors.lastname: Ridderstråle
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D000068959:Body Weight Maintenance; D005260:Female; D018149:Glucose Intolerance / Q000097:blood*; D005951:Glucose Tolerance Test; D006801:Humans; D007333:Insulin Resistance; D008297:Male; D009765:Obesity / Q000097:blood / Q000628:therapy*; D015431:Weight Loss
chemical_list: D001786:Blood Glucose
keywords: Amino acids; Fatty acids; Impaired glucose tolerance; Metabolite profiling; Metabolomics